Moreover, we report a correlation between higher XPA expression in primary tumour tissues and inferior outcome in GCT patients: XPA expression is higher in patients with more advanced disease and poor prognostic features, suggesting a possibility that its increased level may ensure CDDP chemoresistance in primary GCTs and subsequent tumour dissemination and disease progression. The gene discussed is XPA; the disease is granular cell tumor.